XENE logo

Xenon Pharmaceuticals (XENE) Total Liabilities

Annual Total Liabilities

$36.88 M
+$4.23 M+12.95%

31 December 2023

XENE Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$38.09 M
-$1.87 M-4.68%

30 September 2024

XENE Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

XENE Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+3.3%
3 y3 years+67.8%+73.4%
5 y5 years-33.8%-31.6%

XENE Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+67.8%-4.7%+135.1%
5 y5 years-33.8%+106.8%-31.6%+164.7%
alltimeall time-33.8%+1165.1%-31.6%+1206.8%

Xenon Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$38.09 M(-4.7%)
June 2024
-
$39.96 M(+27.6%)
Mar 2024
-
$31.32 M(-15.1%)
Dec 2023
$36.88 M(+12.9%)
$36.88 M(+6.9%)
Sept 2023
-
$34.50 M(-10.3%)
June 2023
-
$38.44 M(+16.8%)
Mar 2023
-
$32.92 M(+0.8%)
Dec 2022
$32.65 M(+48.6%)
$32.65 M(+43.9%)
Sept 2022
-
$22.69 M(+5.1%)
June 2022
-
$21.59 M(+33.2%)
Mar 2022
-
$16.21 M(-26.2%)
Dec 2021
$21.97 M(+23.2%)
$21.97 M(+42.6%)
Sept 2021
-
$15.41 M(-13.1%)
June 2021
-
$17.73 M(+23.2%)
Mar 2021
-
$14.39 M(-19.3%)
Dec 2020
$17.83 M(-68.0%)
$17.83 M(+4.2%)
Sept 2020
-
$17.11 M(-20.0%)
June 2020
-
$21.38 M(-56.4%)
Mar 2020
-
$49.06 M(-11.9%)
Dec 2019
$55.72 M
$55.72 M(+128.9%)
Sept 2019
-
$24.34 M(+5.3%)
June 2019
-
$23.11 M(+3.9%)
DateAnnualQuarterly
Mar 2019
-
$22.24 M(+16.2%)
Dec 2018
$19.13 M(+87.8%)
$19.13 M(-0.9%)
Sept 2018
-
$19.30 M(+30.3%)
June 2018
-
$14.81 M(+59.9%)
Mar 2018
-
$9.26 M(-9.1%)
Dec 2017
$10.19 M(+184.1%)
$10.19 M(+233.1%)
Sept 2017
-
$3.06 M(-19.0%)
June 2017
-
$3.77 M(+5.1%)
Mar 2017
-
$3.59 M(+0.1%)
Dec 2016
$3.59 M(+23.0%)
$3.59 M(-11.7%)
Sept 2016
-
$4.06 M(+34.1%)
June 2016
-
$3.03 M(+1.4%)
Mar 2016
-
$2.99 M(+2.5%)
Dec 2015
$2.92 M(-80.1%)
$2.92 M(-46.9%)
Sept 2015
-
$5.49 M(-55.0%)
June 2015
-
$12.18 M(+16.7%)
Mar 2015
-
$10.43 M(-28.7%)
Dec 2014
$14.64 M(-51.8%)
$14.64 M(-23.6%)
Sept 2014
-
$19.16 M(-18.8%)
June 2014
-
$23.61 M(-22.3%)
Dec 2013
$30.37 M(-40.1%)
$30.37 M
Dec 2012
$50.68 M
-

FAQ

  • What is Xenon Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals quarterly total liabilities year-on-year change?

What is Xenon Pharmaceuticals annual total liabilities?

The current annual total liabilities of XENE is $36.88 M

What is the all time high annual total liabilities for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high annual total liabilities is $55.72 M

What is Xenon Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of XENE is $38.09 M

What is the all time high quarterly total liabilities for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high quarterly total liabilities is $55.72 M

What is Xenon Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, XENE quarterly total liabilities has changed by +$1.22 M (+3.30%)